Variant report
Variant | esv3367734 |
---|---|
Chromosome Location | chr3:46485577-46486322 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:46484352..46487691-chr3:46518831..46521127,3 | K562 | blood: | |
2 | chr3:46484040..46488296-chr3:46490659..46494329,4 | MCF-7 | breast: | |
3 | chr3:46484746..46488003-chr3:46490448..46495431,4 | K562 | blood: | |
4 | chr3:46485067..46487266-chr3:46492253..46493866,2 | K562 | blood: | |
5 | chr3:46479732..46482447-chr3:46484213..46487607,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LTF | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550730490 | chr3:46485613-46485614 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34409943 | chr3:46485631-46485632 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569132945 | chr3:46485706-46485707 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72622926 | chr3:46485773-46485774 | Strong transcription Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs551645646 | chr3:46485873-46485874 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113812049 | chr3:46485874-46485875 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150744266 | chr3:46485900-46485901 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34940840 | chr3:46485955-46485956 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76834810 | chr3:46485959-46485960 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs67168544 | chr3:46485960-46485961 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574014992 | chr3:46485982-46485983 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369115645 | chr3:46486024-46486025 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376676525 | chr3:46486059-46486060 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149485598 | chr3:46486096-46486097 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs111900245 | chr3:46486100-46486101 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557146683 | chr3:46486112-46486113 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575518972 | chr3:46486130-46486131 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565662388 | chr3:46486146-46486147 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539121808 | chr3:46486149-46486150 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192153541 | chr3:46486176-46486177 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564221143 | chr3:46486198-46486199 | Strong transcription Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs573121533 | chr3:46486210-46486211 | Strong transcription Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs112267874 | chr3:46486223-46486224 | Strong transcription Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs143846141 | chr3:46486229-46486230 | Strong transcription Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs561740961 | chr3:46486237-46486238 | Strong transcription Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs576191370 | chr3:46486244-46486245 | Strong transcription Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs71327066 | chr3:46486292-46486293 | Strong transcription Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs550268068 | chr3:46486309-46486310 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Breast cancer | 21509527 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:46455800-46496800 | Strong transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr3:46459400-46491600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
3 | chr3:46465200-46488800 | Weak transcription | Left Ventricle | heart |
4 | chr3:46465200-46488800 | Weak transcription | Right Ventricle | heart |
5 | chr3:46479600-46487000 | Enhancers | Fetal Thymus | thymus |
6 | chr3:46480200-46504000 | Weak transcription | Lung | lung |
7 | chr3:46481000-46488800 | Strong transcription | Spleen | Spleen |
8 | chr3:46481200-46485800 | Weak transcription | Gastric | stomach |
9 | chr3:46483000-46486800 | Weak transcription | Pancreas | Pancrea |
10 | chr3:46483000-46488600 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr3:46483400-46486800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
12 | chr3:46484800-46495000 | Weak transcription | Fetal Intestine Small | intestine |
13 | chr3:46485400-46486200 | Enhancers | Primary T cells from cord blood | blood |
14 | chr3:46485800-46486800 | Strong transcription | Gastric | stomach |